De novo Thrombotic Microangiopathy in Renal Allograft Biopsies—Role of Antibody-Mediated Rejection
Open Access
- 1 August 2010
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 10 (8), 1804-1811
- https://doi.org/10.1111/j.1600-6143.2010.03178.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Peritubular Capillaritis in Renal Allografts: Prevalence, Scoring System, Reproducibility and Clinicopathological CorrelatesAmerican Journal of Transplantation, 2008
- Thrombotic microangiopathy after kidney transplantationTransplant International, 2006
- Cyclosporine withdrawal in post‐renal transplant thrombotic microangiopathyClinical Transplantation, 2005
- Current approaches to treatment of antibody‐mediated rejectionPediatric Transplantation, 2005
- Predictors of Renal Allograft Histologic Damage ProgressionJournal of the American Society of Nephrology, 2005
- De novo thrombotic microangiopathy in renal transplant recipients: A comparison of hemolytic uremic syndrome with localized renal thrombotic microangiopathyAmerican Journal of Kidney Diseases, 2003
- The Banff 97 working classification of renal allograft pathologyKidney International, 1999
- Cyclosporine-associated thrombotic microangiopathy/hemolytic uremic syndrome following kidney and kidney-pancreas transplantationAmerican Journal of Kidney Diseases, 1996
- Hemolytic uremic syndrome in solid-organ transplant recipientsTransplant International, 1996
- Histopathological findings in well-functioning, long-term renal allograftsKidney International, 1992